cbdMD Inc (YCBD)
Official siteHEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • AMEX
Market Cap: $4.88M
Last updated: Nov 17, 2026 at 4:10 PM ET
cbdMD Inc (YCBD) Statistics
cbdMD (YCBD) has a market cap of $4.88M and an enterprise value of $4.62M. Its share count is up 83.57% from a year earlier. It kept -13.80% of revenue as net income over the last 12 months.
Total Valuation
Enterprise value is 5.27% below the market cap, as cash exceeds debt.
| Market Cap | $4.88M |
|---|---|
| Enterprise Value | $4.62M |
| Latest price (Nov 17, 2026) | $0.36 |
Key Dates
The next earnings report is expected on Dec 18, 2026, covering the quarter ending Sep 30, 2026.
| Next Earnings Date | Dec 18, 2026 (expected) |
|---|---|
| Last Earnings Date | Aug 13, 2026 |
| Fiscal Year End | September |
Valuation Ratios
| Forward P/S | 0.2x |
|---|---|
| P/B Ratio | 0.5x |
| P/TBV Ratio | 0.6x |
Price Statistics
The stock is down 43.99% over 52 weeks and trades 12.20% below its 50-day average.
| Beta (1Y) | 0.41 |
|---|---|
| 52-Week Change | -43.99% |
| 1-Month Change | +3.30% |
| 3-Month Change | -26.61% |
| 6-Month Change | -52.05% |
| 5-Year Change | -99.94% |
| Total Return (1Y) | -43.99% |
| Total Return (3Y CAGR) | -59.05% |
| Total Return (5Y CAGR) | -77.22% |
| Max Drawdown (1Y) | -84.67% |
| Max Drawdown (3Y) | -96.04% |
| Sharpe Ratio (1Y) | -0.40 |
| Correlation with SPY (1Y) | 0.04 |
| 50-Day Average | $0.41 |
| 200-Day Average | $0.64 |
| 52-Week Range | $0.33 to $2.56 |
| RSI (14 Days) | 40.5 |
| Average Volume (20 Days) | 171.59K |
The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 2.50x current liabilities, and total debt is 0.23x shareholder equity.
| Current Ratio | 2.50x |
|---|---|
| Quick Ratio | 1.37x |
| Debt / Equity | 0.23x |
Returns and Efficiency
| ROA (5Y Average) | -77.35% |
|---|---|
| ROIC (5Y Average) | -73.62% |
| Asset Turnover | 1.82x |
Scores
YCBD has a Piotroski F-Score of 5 of 9, in the average band of 3 to 7.
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Piotroski F-Score | 5 of 9 |
|---|---|
| Piotroski Strength | Average |
Income Statement
Revenue of $20.93M over the last 12 months is up 10.01% from the 12 months before.
| Revenue | $20.93M |
|---|---|
| Revenue Growth (YoY) | +10.01% |
| Gross Profit | $12.07M |
| Operating Income | -$2.90M |
| Pretax Income | -$2.89M |
| Net Income | -$2.89M |
| EBITDA | -$1.61M |
| Reported EPS (TTM) | -$0.31 |
Trailing 12 months through Jun 30, 2026.
Balance Sheet
Shareholder equity funds 62.43% of the $13.15M in total assets.
| Cash and Equivalents | $2.12M |
|---|---|
| Total Debt | $1.86M |
| Net Cash | $257.02K |
| Net Cash Per Share | $0.02 |
| Working Capital | $4.62M |
| Shareholder Equity | $8.21M |
| Book Value Per Share | $0.77 |
| Tangible Book Value | $6.04M |
| Tangible Book Per Share | $0.57 |
| Total Assets | $13.15M |
| Total Liabilities | $4.93M |
Balance sheet as of Jun 30, 2026.
Cash Flow
After $164.83M of capital spending, operating cash flow left -$167.05M of free cash flow.
| Operating Cash Flow | -$2.22M |
|---|---|
| Capital Expenditures | $164.83M |
| Free Cash Flow | -$167.05M |
| FCF Per Share | -$14.91 |
| Depreciation and Amortization | $246.74M |
Trailing 12 months through Jun 30, 2026.
Margins
The operating margin is -13.87%, against a 5-year average of -77.31%.
| Gross Margin | 57.68% |
|---|---|
| Operating Margin | -13.87% |
| Pretax Margin | -13.80% |
| Net Margin | -13.80% |
| EBITDA Margin | -7.69% |
| FCF Margin | -798.06% |
| Gross Margin (5Y Average) | 63.29% |
| Operating Margin (5Y Average) | -77.31% |
| Net Margin (5Y Average) | -75.03% |
Growth
Revenue fell 18.46% a year over 3 years.
| Revenue Growth (3Y CAGR) | -18.46% |
|---|---|
| Revenue Growth (5Y CAGR) | -14.45% |
Stock Splits
The last split was a 1-for-8 reverse split on May 7, 2025.
| Last Split Date | May 7, 2025 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:8 |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About YCBD
What is YCBD's market cap?
cbdMD has a market cap of $4.88M. Its enterprise value, which adds debt and subtracts cash, is $4.62M.
How many shares of YCBD are outstanding?
cbdMD has 10.62M shares outstanding. The count is up 83.57% from a year earlier.
Does YCBD pay a dividend?
No. cbdMD does not pay a dividend.
How much debt does YCBD have?
cbdMD has $1.86M of total debt and $2.12M of cash and equivalents, a net cash position of $257.02K.
YCBD pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors